4Moving Biotech wins FDA Fast Track for 4P004, but can it finally change the knee osteoarthritis treatment playbook?
4Moving Biotech’s 4P004 won FDA Fast Track in knee osteoarthritis. Read what this means for DMOAD development, trial risk, and regulatory strategy.